The 37-kDa protein annexin 1 (Anx-1; lipocortin 1) has been implicated in the regulation of phagocytosis, cell signaling, and proliferation and is postulated to be a mediator of glucocorticoid action in inflammation and in the control of anterior pituitary hormone release. Here, we report that mice lacking the Anx-1 gene exhibit a complex phenotype that includes an altered expression of other annexins as well as of COX-2 and cPLA 2. In carrageenin-or zymosan-induced inflammation, Anx-1 -/-mice exhibit an exaggerated response to the stimuli characterized by an increase in leukocyte emigration and IL-1β generation and a partial or complete resistance to the antiinflammatory effects of glucocorticoids. Anx-1 -/-polymorphonuclear leucocytes exhibited increased spontaneous migratory behavior in vivo whereas in vitro, leukocytes from Anx-1 -/-mice had reduced cell surface CD 11b (MAC-1) but enhanced CD62L (L-selectin) expression and Anx-1 -/-macrophages exhibited anomalies in phagocytosis. There are also gender differences in activated leukocyte behavior in the Anx-1 -/-mice that are not seen in the wild-type animals, suggesting an interaction between sex hormones and inflammation in Anx-1 -/-animals.
Anx-1, a 37-kDa member of the annexin family, is implicated in control of cell growth (2) and differentiation (3) , signal transduction and arachidonic acid release (4, 5) , as well as intracellular vesicle trafficking (6) (7) (8) . In mammals, glucocorticoids regulate the synthesis, phosphorylation and cellular disposition of Anx-1, and work from our laboratory, as well as from others, has provided evidence for the involvement of Anx-1 in the regulation by these drugs of leukocyte migration (9) , acute (10) and chronic (11) inflammation, ischaemic damage (12) (13) (14) , pain (15) , and fever (16) . In the rodent anterior pituitary gland, the inhibition of ACTH (17) and other (18) hormone release by glucocorticoids is mediated through an Anx-1-dependent mechanism.
Until now, most studies probing Anx-1 function have relied on the provision of tools such as neutralizing antibodies, anti-sense agents, recombinant normal and chimeric proteins, and peptidomimetics to elucidate the scope and range of Anx-1 actions. To clarify further the role of this protein, we have generated, for the first time, an Anx-1 null mouse line and compared its sensitivity to inflammatory stimuli and its response to glucocorticoids with that of wild-type controls.
MATERIALS AND METHODS

Preparation of Anx-1 -/-mice
We generated an Anx-1 -/-mouse by using conventional techniques and a dual-purpose targeting vector designed to simultaneously inactivate the gene and report on the activity of the Anx-1 promoter. We isolated genomic clones spanning the Anx-1 locus from a 129/SvJ lambda library (Stratagene, La Jolla, CA) by standard methods (19) . Inserts were sized and mapped for comparison with the gene from the Balb/c strain (20) . A short region near the center of the locus was missing from the lambda clones. We recovered this region by polymerse chain reaction (PCR) of genomic DNA, using primers based on sequences obtained from near the ends of clones P2 and 290. The sequence of the primers was TGGACATGCTAGGAAGGGACAAC for P2f and ATATGAGCAAACTGAGCGTCTGTG for 290r. Reaction conditions were 94°C for 45 s/52ºC for 45 s/72ºC for 3 min for 30 cycles, generating a product of 2.5 kb that was subcloned into the TA vector pCR2.1 (Invitrogen, Groningen, The Netherlands). We performed electroporation of the targeting construct and drug selection of embryonic stem cells according to the method of Hogan et al. (21) and identified correctly targeted clones by Southern blotting, using probes located both 5' and 3' of the vector arms, karyotyped by G banding, and then used these to produce chimeras by blastocyst injection.
We mated chimeras to C57bl/6 females to produce heterozygotes, which were then mated together to produce homozygous Anx-1 -/-mice. We genotyped offspring by Southern blotting and also by multiplex PCR of tail-clip DNA, using primers located in exon 3 (GCCTTGCACAAAGCTATCATGG) and exon 4 (GCATTGGTCCTCTTGGTAAGAATG) for detection of the wild-type allele, and we used primers located in the Lac Z coding sequence (TACTGTCGTCGTCCCCTCAAACTG and GTTGCACCACAGATGAAACGC) to detect the targeted allele. The reaction conditions were 94°C for 45 s/55°C for 30 s/72°C for 45 s for 30 cycles, and the products formed were 700 bp for the wild-type and 220 bp for the targeted allele. Mice used for experimental purposes were littermate controls or matched as closely as possible for age and sex.
All procedures carried out using animals were performed in accordance with The UK Home Office regulations and were approved by the Animal Ethics Committee of our institution.
Lac Z staining and tissue distribution of proteins
We collected postmortem tissue samples from Anx-1 +/+ , Anx-1 +/-, and Anx-1 -/-animals and measured the Lac Z content by the method of Hogan et al. (21) by using chlorophenol red-β-Dgalactopyranoside (CPRG) as substrate, according to the supplier's instructions (Stratagene). For sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting, we prepared tissue extracts in a conventional manner and used the National Institutes of Health Image vs. 1.54 densitometric analysis program to provide a semiquantitative analysis of scanned blots and to report relative band intensities as percentage changes within each blot.
Anx-1 antisera was raised in house. Antisera to annexins II, IV, V, and VI and COX-2 and cPLA 2 were from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-actin was from Sigma (Poole, Dorset, UK).
Mouse paw carrageenin edema
We divided male or female Anx-1 +/+ or Anx-1 -/-mice weighing 25-30 g into groups (n=7-9) and used the technique of Henriques et al. (22) to induce inflammation. In brief, mice were lightly anaesthetized with enflurane and received subplantar administration of 50 µl of carrageenin 1% w/v. Paw swelling was measured using a hydroplethysmometer specially modified for small volumes (Ugo Basile, Milan, Italy) immediately before the subplantar injection and at 6, 24, 48, 72, and 96 h thereafter. The increase in paw volume was evaluated as the difference between the paw volume at each time point and the basal reading. Dexamethasone (10 µg/kg) or vehicle was given i.p. at 0, 6, 24, and 48 h.
Zymosan peritonitis
We induced zymosan peritonitis in groups (7-9) of mice (20-25 g ) of all genotypes as previously reported by us (10, 23) . In brief, peritonitis was induced by i.p. injection of 1 mg zymosan A dissolved in 0.5 ml of sterile saline. Animals were killed by exposure to carbon dioxide at various time intervals (2-24 h), and the peritoneal cavities were lavaged with 3 ml of phosphatebuffered saline (PBS) containing 3 mM EDTA. At these time points, 80-90% of the cells recovered were granulocytes (mostly neutrophils), with <5% being eosinophils (as determined on cytospin preparations following staining with hematoxylin and eosin). The lavage fluids were centrifuged at 400g for 10 min, and cell-free supernatants were stored at -20 o C for quantitation of inflammatory mediators by ELISA. To assess the action of glucocorticoids, we gave dexamethasone or vehicle (0.1 mg/kg i.p.) 30 min before the experiment.
Intravital microscopy of the mouse mesenteric circulation
We used male or female Anx-1 +/+ or Anx-1 -/-mice (12-15 g) for these experiments. In brief, mice were anaesthetized with diazepam (60 mg/kg s.c.) and Hypnorm (fentanyl citrate 0.7 mg/kg and fluanisone 20 mg/kg i.m.), cautery incisions were made along the abdominal region; and the mesenteric vascular bed was exteriorized and placed on a viewing Plexiglass stage. The preparation was then mounted on a Zeiss Axioscop FS (Zeiss plc, Welwyn Garden City, UK) with a water immersion objective lens (magnification 40×; Zeiss), and an eyepiece (magnification, 10×; Zeiss) was used to observe the microcirculation. We made microscopic observations 1-4 h later and analyzed the white blood cell velocity, adhesion, and emigration off line as previously described by us (24) .
CD11b and CD62L expression
We obtained blood, pooled from at least four or five Anx-1 +/+ or Anx-1 -/-mice, by cardiac puncture and incubated aliquots (950 µl) with various concentrations of platelet activating factor, formyl-methionyl-leucyl-phenylalanine, or vehicle for 15 min at 37°C before washing them with PBS (+3% NaNa 3 ). We stained the cells with a specific rat anti-murine CD11b, or anti-CD62L, monoclonal antibody followed by an appropriate FITC-labeled second antibody and used a Becton Dickinson (Oxford, UK) FACscan to measure the median fluorescence intensity in the FL1 channel (548 nM) and thus estimated the number of molecules of endogenous CD11b and CD62L per cell. In some experiments, we permeabilized cells with 0.05% saponin so that we could determine the total CD11b content.
Measurement of inflammatory mediators
We used commercially available enzyme immunoassay kits (Amersham Pharmacia Biotech, Buckinghamshire, UK; R&D Systems, Abingdon, UK) to measure PGE 2 and immunoreactive murine IL-1β and tumor necrosis factor (TNF)-α levels in cell-free exudates of peritoneal lavage fluids at various times after injection of zymosan. We calculated the results by reading the optical density of the final reaction products, using a Molecular Devices (Sunnyvale, CA) microtiter plate reader.
Macrophage phagocytosis
We obtained peritoneal macrophages by lavage from male or female Anx-1 +/+ , Anx-1 +/-, or Anx-1 -/-mice; divided them into aliquots of 5×10 6 cells (>80% macrophages); and incubated them in at 37°C for 30 min in a total volume of 500 µl of RPMI 1640 supplemented with 2% fetal calf serum together with different concentrations of vehicle or glucocorticoids (cortisol/cortisone, 10 µM). We then diluted the cells to 1.0×10 6 /ml in Kreb's solution and used a FACscan to monitor the uptake of 10 µl of Red Oxyburst immunocomplexes. To measure zymosan uptake, we incubated cells with 100 µg/ml opsonized or unopsonized zymosan at 37°C and, using light microscopy, counted the percentage of cells taking up particles after 2 h.
Statistical methods
Data was assessed for normality using the Shapiro-Wilk test and thereafter were analyzed using parametric (ANOVA, unpaired Student's t test) or nonparametric (Kruskal-Wallis, MannWhitney) tests as appropriate. Usually, two-tailed tests were applied and a value of P<0.05 was accepted as being significant.
RESULTS
Production of Anx-1 null mice
The construction of the dual-purpose targeting vector designed to simultaneously inactivate the gene and report on the activity of the Anx-1 promoter is shown in Figure 1A -C. Southern blot analysis of tail-clip DNA digested with Kpn I revealed the wild-type allele running as a band of 35 kb, whereas the targeted allele generates the expected band of 18 kb (Fig. 1D) . We confirmed this result by genotyping tail clip DNA by multiplex PCR (Fig. 1E) . From the initial heterozygote crosses, 102 (53 male, 49 female) wild-type mice were produced (predicted: 120); 244 (130 male, 114 female) heterozygote offspring (240 were predicted) and 133 null mice (78 males, 55 female) were seen (predicted: 120). This confirms that the mutated gene was passed on according to the expected Mendelian pattern.
There was no obvious difference between the Anx-1 -/-, Anx-1 +/-, and Anx-1 +/+ littermate control mice in terms of gross physical appearance or behavior, and we saw no significant variations in weight between any of the (sex-matched) groups at any time point examined. All animals appeared healthy, although in a limited ongoing longevity study, 1 or 4 Anx-1 -/-mice died at age 11 months (female; abdominal tumor), whereas we saw no deaths (0 of 4) in the control group. Anx-1 -/-animals bred normally producing healthy Anx-1 -/-offspring: There was no evidence of impaired fertility in either males or females and no significant differences between the length of gestation, litter size or sex ratio in any of the possible crosses between the three genotypes.
Anx-1 gene deletion leads to up-regulation of expression of other annexins, COX-2, and cPLA 2 in some tissues
We estimated the expression of the Anx-1 gene in organs removed postmortem from Anx-1 -/-mice by measuring the content of Lac-z colorimetrically. There was strong gene expression in stomach, lung, spleen, ovary, and uterus, whereas kidney, thymus, and heart had intermediate levels of expression. Expression was detected in thyroid, pancreas, and testes, but none was observed under the (time-limited) assay conditions in brain (mainly cortex), liver, or adrenal gland ( Fig. 2A) .
Because of the strong homology between members of the annexin family and thus the possibility of compensatory changes, we also screened tissues from all genotypes for changes in the expression of annexins 1, 2, 4, 5, and 6 as well as COX-2 and cPLA 2 . In terms of the general tissue distribution of proteins, Anx-5 was the least abundant member of the family--detectable amounts were present only in the lung in our experiments. Anx-6 was absent from the testis but present in all other tissues examined, whereas Anx-1, -2, and -4 were present in variable amounts in all tissues examined with the exception of the anterior pituitary gland, where Anx-2 was absent. COX-2 was readily identified in all organs except for the testis, whereas cPLA 2 could only be identified under our experimental conditions in the thymus, lung, and spleen. As anticipated, there was no detectable Anx-1 in the tissues taken from the Anx-1 -/-null mice, and the amount present in the heterozygotes was clearly less than that in the Anx-1 +/+ littermate controls.
We observed several genotype-dependent changes (relative to Anx-1 +/+ mice and corrected for actin staining) in the relative abundance of other annexins: In lung tissue (Fig. 2B) , the amount of Anx-1 protein was reduced in the Anx-1 +/-(44% males; 52% females) and absent, as expected, in the Anx-1 -/-mice. This was accompanied by a strong up-regulation in Anx-2 (406% male -/-and 119% female -/-), Anx-4 (292% male -/-and 175% female -/-), Anx-5 (111% male -/-and 196% female -/-), and Anx-6 (121% male -/-and 132% female -/-) in both sexes. In addition to the changes in annexins, the expression of cPLA 2 (205% male -/-and 268% female -/-) and COX-2 (145% male -/-and 299% female -/-) was increased in the Anx-1 +/-and Anx-1 -/-animals.
In thymus tissue (Fig. 2C) , the amount of Anx-1 protein was reduced in Anx-1 +/-animals of both sexes (57% males; 61% females) and was absent in null animals. As in the lung, we saw that the reduction in Anx-1 was accompanied by an increase in the expression of other family members. Anx-2 was increased (285% males -/-only) as was Anx-4 (203% male -/-only), COX-2 (3600% male -/-and 8400% female -/-), and cPLA 2 (18900% male -/-and 348% female -/-). Anx-5 was not detected in our thymus preparations, and Anx-6 was largely unchanged.
We observed (data not shown) less dramatic and more selective up-regulation of annexins in the spleen (Anx-2 and -6), stomach (Anx-2), and kidney (Anx-4). In some tissues, annexins were down-regulated apparently as a consequence of the removal of Anx-1. This included the ovary (Anx-2, -4, and -6), the liver (Anx-2 and -4), the kidney and the stomach (Anx-6: females only), and the heart and anterior pituitary gland (Anx-6). There was no apparent genotype-dependent change in any of the annexins measured in the gut or the testis. There was also no apparent change in COX-2 in the adrenal, spleen, ovary, heart, liver, kidney, stomach, or gut and likewise no apparent genotype-linked change in cPLA 2 in the spleen.
Inflammation is exacerbated in Anx-1 -/-mice and partially resistant to dexamethasone
We used two models of acute inflammation to evaluate the effects of the absence of the Anx-1 gene. Mouse paw carrageenin-induced edema follows a characteristic biphasic pattern (22), with the first phase peaking at 4-6 h and resolving at 24 h, and the second peaking at 72 h and resolving at >96 h. In a carefully age-and weight-matched experiment using only male animals (mean age of Anx-1 +/+ mice, 60.7±0.3 days; mean age of Anx-1 -/-mice, 61±0 days), Anx-1 -/-mice displayed enhanced sensitivity to this inflammatory stimulus with greater paw swelling being observed at most time points and being statistically significant at 6, 24, and 96 h (Fig 3A) . In a second type of experiment, we examined the effect of glucocorticoids on paw edema by using a larger (n=17-18) group of mixed-sex animals. We observed that dexamethasone (10 µg/kg × 3, i.p.) strongly inhibited the first phase of edema [mainly PMN-dependent (22)] in Anx-1 +/+ mice but was completely without effect in Anx-1 -/-mice (Fig. 3B ). In contrast, there was no change in glucocorticoid sensitivity of the second (>24 h) phase [mainly macrophage-, lymphocyte-, and eosinophil-dependent (22)] of the edema (Fig. 3C) .
We chose zymosan-induced peritonitis as a second inflammatory protocol. Again, in experiments with matched groups, we noted a substantial increase in PMN migration at all time points in the Anx-1 -/-mice relative to their Anx-1 +/+ counterparts, whereas at 4 and 6 h, the response in the Anx-1 -/+ animals was intermediate (Fig. 4A) . To further probe the inflammatory mechanism, we measured cytokine and PGE 2 levels at 2 and 4 h. Unlike cell migration, the cytokine levels differed between males and females, and the data from the two sexes were treated separately. By 2 h, IL-1β levels were higher in females than in males (299.8 ±90.1 ng/ml vs. 142.6 ± 29.6 ng/ml, respectively; P=0.01) but were significantly increased in Anx-1 null animals in both sexes (Fig. 4B ). These differences had disappeared by 4 h. TNF-α levels in Anx-1 +/+ mice also were higher in females than in males (females, 1056.8 ng/ml; semiquartile range 990.0-1331.15 ng/ml; males, 524.7 ng/ml; semiquartile range 312.96-868.96 ng/ml; P=0.013), but although there was a trend, these levels were not significantly elevated in the Anx-1 -/-null animals (males, 852.3 ng/ml; semiquartile range 693.5-1068.3:females, 1249.38 ng/ml, 771.6-1249.4 ng/ml). Perhaps somewhat surprisingly in view of the overexpression of cPLA 2 and COX-2 seen in some tissues, we saw no difference in the amounts of PGE 2 between the Anx-1 +/+ and Anx-1 -/-mice at these time points.
We also tested dexamethasone in this model. At an approximate ED 50 dose of 0.1 mg/kg, the steroid produced 49.2% inhibition of PMN emigration in Anx +/+ mice but progressively less in Anx +/-(36.1%) and Anx -/-mice (22.3%), respectively (Fig. 4C) .
In some experiments, we quantitated peripheral blood cells during the course of zymosan peritonitis. In untreated animals, there was no significant difference between the absolute numbers of monocytes, PMN, and lymphocytes between male and female mice, and there was no difference between the numbers of peripheral cells associated with the different genotypes. However, we found that after 4 h peritonitis, there was a profound alteration in the disposition of peripheral blood cells in female, although not in male, Anx-1 -/-animals and that this was mainly accounted for by a dramatic fall in circulating PMN (Fig. 4D) . Historical FACS data (data not shown) from our laboratory indicate that membrane Anx-1 is observed mainly on circulating murine PMN and monocytes but not on lymphocytes (8±1, 13±1, and 0 ×10 3 Anx-1-like immunoreactive molecules, respectively) and that cytosolic Anx-1 follows a broadly similar distribution (44±4, 35±5, and 5±1 ×10 3 Anx-1-like immunoreactive molecules, respectively).
Leukocytes from Anx-1 -/-mice have altered adhesion molecule expression and display phagocytic and other abnormalities
To determine whether the changes in the magnitude of inflammation seen in Anx-1 -/-mice could be traced to differences in leukocyte behavior, we measured changes in the expression of cell surface adhesion molecules, PMN migratory behavior, and macrophage phagocytosis. CD11b expression on PMN and monocytes from male and female Anx-1 -/-mice were significantly reduced (-32% and -28.5%, respectively) compared with Anx-1 +/+ controls, whereas CD62L expression was significantly enhanced (+27.8% and +30.0%, respectively; Fig. 5A ). This reduction in CD11b was not caused by changes in distribution of the molecule alone; permeabilized cells contained correspondingly less total CD11b than Anx-1 +/+ cells (data not shown). In contrast, CD11b expression on PMN and monocytes taken from Anx-1 -/-mice was more sensitive to activation by FMLP (1-10 µM) or PAF (0.3-3.0 µM) than their Anx-1 +/+ counterparts ( Fig. 5B-E) .
Because phagocytosis of zymosan (the irritant used in one of our inflammatory protocols) is accompanied by the release of inflammatory mediators, we assessed the phagocytic activity of peritoneal lavage macrophages in the three genotypes. Using light microscopy, we found in two initial experiments (performed in triplicate) that unopsonized zymosan was taken up by ∼50% of Anx-1 +/+ cells after 2 h, but a decreasing proportion of phagocytozing cells was seen in preparations obtained from Anx-1 +/-and Anx-1 -/-mice. Uptake of opsonized zymosan was greater in cells from all phenotypes, but again, there was a clear genotype-dependent difference in uptake (Fig. 6A) . To investigate further this phagocytic defect, we examined phagocytosis of aggregated IgG, using the Red Oxyburst technique followed by a FACS analysis and assessed the slope (e.g., the rate) and the maximum of the reaction graphically. Although there were some variations, phagocytosis of IgG was not significantly different between any of the control groups tested. The glucocorticoids hydrocortisone and cortisone produced comparable inhibitory effects (20-30%) on IgG phagocytosis at a (near maximal) concentration of 10 µM in Anx-1 +/+ animals but were totally inactive in cells from Anx-1 -/-mice. Anx-1 +/-cells displayed an intermediate response (Fig. 6B) . Because glucocorticoids are thought to function in this model by promoting the externalization of Anx-1, we also tested in one experiment the efficacy of the Anx-1 mimetic peptide N-acetyl 2-26 (24) . The peptide (10 µM) produced inhibitory effects in the cells from both groups (22.0 ± 1.9% inhibition of maximum and 11.9 ± 2.3% of the rate in the Anx-1 +/+ and 18.9 ± 2.1 % and 9.7 ± 6 % in Anx-1 -/-animals, respectively), indicating that the failure of glucocorticoids to inhibit the response was not caused by lack of sensitivity to Anx-1.
Using intravital microscopy in the mouse mesentery, we also investigated the effects of genotype on the behavior of leukocytes in the microcirculation under unstimulated conditions. There was no significant difference in the velocity of rolling of Anx 
DISCUSSION
Despite suggestions that annexins are involved in human disease (25) , few attempts to use transgenic or gene deletion strategies to probe their function in pathophysiology have been made--and these have met with mixed success. Anx-6 -/-mice are viable and fertile with no detectable abnormalities in the cardiovascular or immune systems (26) . However, overexpression of this gene disrupts normal Ca 2+ homeostasis in the heart and leads ultimately to cardiac failure (27) . The situation of Anx-7 is confusing; one group reports that deletion of this gene is a lethal mutation (28) , and another finds that the mutants are viable, fertile, and show no obvious phenotype, although there were indications of altered electromechanical coupling in cardiomyocytes from these animals (29) .
Anx-1 is a clear candidate for testing in transgenic models because of the wealth of evidence that it is involved in the action of the glucocorticoids and the regulation of inflammation and the neuroendocrine function in experimental models. In human disease too, defects in Anx-1 function are implicated in familial Mediterranean fever (30, 31) , fragile X syndrome (32) , and Weber-Christian disease (33) . Anx-1 has an abnormal metabolism in cystic fibrosis (34) and other lung disorders (35) (36) (37) and has been implicated directly or indirectly in the control of human cell division (2) or differentiation (3) and tumor development, (38) skin disorders (39, 40) , and central nervous system pathology (41, 42) . Auto antibodies to Anx-1 may be responsible for some forms of glucocorticoid resistance in rheumatoid patients, (43) associated with the pathology of systemic lupus erythematosus (44) and Crohn's disease (45) and could be a diagnostic marker for certain types of tumors (46) . The protein is elevated or released in humans after systemic (47, 48) or local (49) administration of glucocorticoids, and endogenous levels in circulating monocytes correlate with the activity of the hypothalamo-pituitary axis in normal, Cushingoid, and Addisonian patients (50) .
As in the case of Anx-6 and (possibly) Anx-7, it seems that Anx-1 gene deletion is not a lethal mutation and that animals grow to sexual maturity without any obvious developmental problem (26, 29) . One striking change we observed in this study was the altered expression of other members of the annexin family together with the overexpression of COX-2 and cPLA 2 in the lung and thymus as well as some other tissues. These data suggest that there may be some form of reciprocal regulation between annexin family members and that inducible COX-2 and cPLA 2 enzymes may also be indirectly affected by the gene deletion, a finding that is congruent with some published observations (51, 52).
In our previous attempts to delineate the role of Anx-1 in physiopathology, we used acute passive immunization strategies. In models of acute inflammation in the rodent, such as the zymosan-inflamed air pouch, our chief findings were that the administration of Anx-1-neutralizing antibodies exacerbated inflammation as assessed by PMN influx, cytokine and eicosanoid synthesis, and resolution of the response (53) . In models designed to mimic activation of the HPA axis during infection or inflammation, passive immunization blocked the inhibitory effects of exogenous corticosterone or dexamethasone on IL-1β-induced increases in adrenocorticotrophic hormone (54, 55) . Similarly, passive immunization studies have suggested that the capacity of glucocorticoids to counter the regulatory action of cytokines on the secretion of growth hormone and prolactin is dependent on Anx-1 (55).
These findings were echoed here by the marked differences we saw between the Anx-1 +/+ and Anx-1 -/-mice. The glucocorticoids can of course operate through a variety of mechanisms to bring about their effects, including inhibition of NF-κB activation and direct genomic actions mediated through glucocorticoid response elements as well as other signaling pathways (4, 56, 57) . Because of the apparent redundancy of glucocorticoid mechanisms, it would be surprising if every effect of these drugs was suppressed in the Anx-1 -/-animals. That our results suggest that glucocorticoids use separate parallel pathways to regulate inflammation is congruent with the observation that recombinant Anx-1 exerts antiinflammatory effects in some, but not all, types of inflammation models (58) .
In attempting to account for the exaggerated inflammatory response of Anx-1 -/-mice, we observed several changes in these animals that could be mechanistically relevant. There was an early increase in IL-1 β in inflammatory peritoneal exudates in the Anx-1 -/-mice and an enhanced tendency for Anx-1 -/-PMN to adhere to, and to migrate from, postcapillary venules, perhaps secondary to up-regulated CD62L expression, and a super sensitivity of cells to agents that up-regulate CD11b expression (perhaps contributing to the profound neutropenia seen in female Anx-1 -/-mice). Our results provide support for previous suggestions that Anx-1 regulates CD62L expression (59) . One can speculate that all these factors taken together would culminate into an enhanced emigration in response to inflammatory stimuli such as we observed.
Anx-1 inhibits phagocytosis to a moderate degree (60), so we were surprised that Anx-1 -/-cells exhibited a compromised ability to take up unopsonized zymosan particles. However, macrophages use CD11b together with CD18 for zymosan internalization (61) , providing a possible explanation, although Anx-1 has also been implicated more directly in the mechanism of phagocytosis (62, 63, 64) . In view of the fact that IgG phagocytosis appears to be normal, the defect in phagocytosis appears restricted to zymosan and it is possible that the size of the particles (zymosan vs. aggregated IgG) could be the cause of the differences seen.
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